Johnson & Johnson JNJ StarRatingValueLabel_3

Last Price
86.82
Day Change
-0.39|-0.45%

As of 24/05/2013
16:01:14 EDT | USD  Minimum 15 Minutes Delay.

Bid/OfferDay RangeVolume90d Ave VolMkt Cap
86.64 - 86.9986.49 - 87.0310,390,046- 243.9 Bil
Last Close52 Week RangeP/EYield %ISIN
87.2161.71 - 89.9923.562.87US4781601046

Johnson & Johnson Share Price

Morningstar's Take JNJ

Johnson & Johnson stands alone as a leader across the major health-care industries. The company maintains a diverse revenue base, a robust research pipeline, and exceptional cash flow generation that together create a wide economic moat.

Fair Value Estimate

87.00 USD

Uncertainity

- Avg

Economic Moat

Wide

Financial Health

Financial Health
Financials
Annual
201020112012
more...
Income Statement
Revenue61,58765,03067,224
Operating Income16,52716,15315,869
Net Income13,3349,67210,853
Basic EPS4.853.543.94
Avg. Diluted Shares Outstanding2,7892,7752,813
Balance Sheet
Current Assets47,30754,31646,116
Non Current Assets55,60159,32875,231
Total Assets102,908113,644121,347
Current Liabilities23,07222,81124,262
Total Liabilities46,32956,56456,521
Shareholder Equity56,57957,08064,826
Cash Flow
Cash From Operations16,38514,29815,396
Capital Expenditure-2,384-2,893-2,934
Free Cash Flow14,00111,40512,462

In millions, except "Basic EPS". Currency is USD.

Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the health care field.

Sector

Healthcare

Industry

Drug Manufacturers - Major

Stock Style

Large-Value

Fiscal Year Ends

December

Employees

127600
Key Stats
more...
Price/Earning TTM23.11
Price/Book-
Price/Sales TTM3.60
Rev Growth (3 year avg)2.79
EPS Growth (3 year avg)-4.27
Operating Margin % TTM23.61
Net Margin % TTM16.14
ROE TTM17.81
Debt/Equity1.87
Dividends
PreviousLatest
Declared Date17/10/1202/01/13
Ex-Div23/11/1222/02/13
Paid11/12/1212/03/13
Amnt0.610.61